188 related articles for article (PubMed ID: 24162754)
1. Self-assembling colloidal system for the ocular administration of cyclosporine A.
Luschmann C; Tessmar J; Schoeberl S; Strauß O; Luschmann K; Goepferich A
Cornea; 2014 Jan; 33(1):77-81. PubMed ID: 24162754
[TBL] [Abstract][Full Text] [Related]
2. Novel micelle carriers for cyclosporin A topical ocular delivery: in vivo cornea penetration, ocular distribution and efficacy studies.
Di Tommaso C; Bourges JL; Valamanesh F; Trubitsyn G; Torriglia A; Jeanny JC; Behar-Cohen F; Gurny R; Möller M
Eur J Pharm Biopharm; 2012 Jun; 81(2):257-64. PubMed ID: 22445900
[TBL] [Abstract][Full Text] [Related]
3. Ocular delivery systems for poorly soluble drugs: an in-vivo evaluation.
Luschmann C; Herrmann W; Strauss O; Luschmann K; Goepferich A
Int J Pharm; 2013 Oct; 455(1-2):331-7. PubMed ID: 23867983
[TBL] [Abstract][Full Text] [Related]
4. Poloxamer 407/TPGS Mixed Micelles as Promising Carriers for Cyclosporine Ocular Delivery.
Grimaudo MA; Pescina S; Padula C; Santi P; Concheiro A; Alvarez-Lorenzo C; Nicoli S
Mol Pharm; 2018 Feb; 15(2):571-584. PubMed ID: 29313693
[TBL] [Abstract][Full Text] [Related]
5. Semifluorinated alkane based systems for enhanced corneal penetration of poorly soluble drugs.
Agarwal P; Scherer D; Günther B; Rupenthal ID
Int J Pharm; 2018 Mar; 538(1-2):119-129. PubMed ID: 29339249
[TBL] [Abstract][Full Text] [Related]
6. Improving the topical ocular pharmacokinetics of lyophilized cyclosporine A-loaded micelles: formulation, in vitro and in vivo studies.
Yu Y; Chen D; Li Y; Yang W; Tu J; Shen Y
Drug Deliv; 2018 Nov; 25(1):888-899. PubMed ID: 29631468
[TBL] [Abstract][Full Text] [Related]
7. Developing an in situ nanosuspension: a novel approach towards the efficient administration of poorly soluble drugs at the anterior eye.
Luschmann C; Tessmar J; Schoeberl S; Strauss O; Framme C; Luschmann K; Goepferich A
Eur J Pharm Sci; 2013 Nov; 50(3-4):385-92. PubMed ID: 23880334
[TBL] [Abstract][Full Text] [Related]
8. Novel microemulsion in situ electrolyte-triggered gelling system for ophthalmic delivery of lipophilic cyclosporine A: in vitro and in vivo results.
Gan L; Gan Y; Zhu C; Zhang X; Zhu J
Int J Pharm; 2009 Jan; 365(1-2):143-9. PubMed ID: 18773948
[TBL] [Abstract][Full Text] [Related]
9. Effect of cyclosporine A formulations on bovine corneal absorption: ex-vivo study.
Le Bourlais CA; Chevanne F; Turlin B; Acar L; Zia H; Sado PA; Needham TE; Leverge R
J Microencapsul; 1997; 14(4):457-67. PubMed ID: 9229345
[TBL] [Abstract][Full Text] [Related]
10. Ocular biocompatibility of novel Cyclosporin A formulations based on methoxy poly(ethylene glycol)-hexylsubstituted poly(lactide) micelle carriers.
Di Tommaso C; Torriglia A; Furrer P; Behar-Cohen F; Gurny R; Möller M
Int J Pharm; 2011 Sep; 416(2):515-24. PubMed ID: 21219997
[TBL] [Abstract][Full Text] [Related]
11. Polymeric micelles for the solubilization and delivery of cyclosporine A: pharmacokinetics and biodistribution.
Aliabadi HM; Brocks DR; Lavasanifar A
Biomaterials; 2005 Dec; 26(35):7251-9. PubMed ID: 16005061
[TBL] [Abstract][Full Text] [Related]
12. Hyaluronic acid coated poly-epsilon-caprolactone nanospheres deliver high concentrations of cyclosporine A into the cornea.
Yenice I; Mocan MC; Palaska E; Bochot A; Bilensoy E; Vural I; Irkeç M; Hincal AA
Exp Eye Res; 2008 Sep; 87(3):162-7. PubMed ID: 18675411
[TBL] [Abstract][Full Text] [Related]
13. Comparison of 1% cyclosporine eye drops in olive oil and in linseed oil to treat experimentally-induced keratoconjunctivitis sicca in rabbits.
Parrilha LR; Nai GA; Giuffrida R; Barbero RC; Padovani LD; Pereira RH; Silva DA; Silva MC; Diniz MS; Andrade SF
Arq Bras Oftalmol; 2015; 78(5):295-9. PubMed ID: 26466228
[TBL] [Abstract][Full Text] [Related]
14. Penetration of cyclosporin A into the rabbit cornea and aqueous humor after topical drop and collagen shield administration.
Kanpolat A; Batioglu F; Yilmaz M; Akbas F
CLAO J; 1994 Apr; 20(2):119-22. PubMed ID: 8044977
[TBL] [Abstract][Full Text] [Related]
15. New micelle myricetin formulation for ocular delivery: improved stability, solubility, and ocular anti-inflammatory treatment.
Sun F; Zheng Z; Lan J; Li X; Li M; Song K; Wu X
Drug Deliv; 2019 Dec; 26(1):575-585. PubMed ID: 31172843
[TBL] [Abstract][Full Text] [Related]
16. Distribution of cyclosporine A in ocular tissues after topical administration of cyclosporine A cationic emulsions to pigmented rabbits.
Daull P; Lallemand F; Philips B; Lambert G; Buggage R; Garrigue JS
Cornea; 2013 Mar; 32(3):345-54. PubMed ID: 23023401
[TBL] [Abstract][Full Text] [Related]
17. Stability, safety, and transcorneal mechanistic studies of ophthalmic lyophilized cyclosporine-loaded polymeric micelles.
Shen Y; Yu Y; Chaurasiya B; Li X; Xu Y; Webster TJ; Tu J; Sun R
Int J Nanomedicine; 2018; 13():8281-8296. PubMed ID: 30584300
[TBL] [Abstract][Full Text] [Related]
18. Silk Fibroin Formed Bioadhesive Ophthalmic Gel for Dry Eye Syndrome Treatment.
Hao T; Tang L; Xu Q; Wang W; Li Z; Shen Y; Xu B; Luo H; Li Q; Wang J; Zhang J
AAPS PharmSciTech; 2024 Apr; 25(5):92. PubMed ID: 38684590
[TBL] [Abstract][Full Text] [Related]
19. Semifluorinated alkanes as a liquid drug carrier system for topical ocular drug delivery.
Dutescu RM; Panfil C; Merkel OM; Schrage N
Eur J Pharm Biopharm; 2014 Sep; 88(1):123-8. PubMed ID: 24844949
[TBL] [Abstract][Full Text] [Related]
20. Targeted cutaneous delivery of ciclosporin A using micellar nanocarriers and the possible role of inter-cluster regions as molecular transport pathways.
Lapteva M; Santer V; Mondon K; Patmanidis I; Chiriano G; Scapozza L; Gurny R; Möller M; Kalia YN
J Control Release; 2014 Dec; 196():9-18. PubMed ID: 25278258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
